Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Salloway

Showing results (51-60 of 174) with videos related to

Pageof 18
Sort By:
Journal of the International Neuropsychological Society : JINS|September 20, 2024
Psychometric and adherence considerations for high-frequency, smartphone-based cognitive screening protocols in older adultsLouisa I Thompson, Alyssa N De Vito, Zachary J Kunicki, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 20, 2025
TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's diseaseStephen Salloway, Andrew Pain, Elly Lee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 29, 2023
Remote and in-clinic digital cognitive screening tools outperform the MoCA to distinguish cerebral amyloid status among cognitively healthy older adultsLouisa I Thompson, Zachary J Kunicki, Sheina Emrani, et al.
JAMA Neurology|November 18, 2024
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer DiseaseStephen Salloway, Jakub Wojtowicz, Nicola Voyle, et al.
JAMA Network Open|July 13, 2026
Age, Multidomain Lifestyle Intervention, and White Matter Integrity: Secondary Analysis of the POINTER Randomized Clinical TrialPauline Maillard, Prashanthi Vemuri, Danielle J Harvey, et al.
Annals of Neurology|March 26, 2011
Amyloid-β associated cortical thinning in clinically normal elderlyJ Alex Becker, Trey Hedden, Jeremy Carmasin, et al.
Brain : a Journal of Neurology|January 13, 2017
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognitionMichael J Pontecorvo, Michael D Devous, Michael Navitsky, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentLuka Kulic, Fabien Alcaraz, Gregory Klein, et al.
Journal of the International Neuropsychological Society : JINS|January 29, 2016
Two Novel Psychomotor Tasks in Idiopathic Normal Pressure HydrocephalusMaria A Rossetti, Irene Piryatinsky, Fayeza S Ahmed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 3, 2024
Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumabTianle Chen, John O'Gorman, Carmen Castrillo-Viguera, et al.
Pageof 18

Showing results (51-60 of 174) with videos related to

Sort By:
Pageof 18
Journal of the International Neuropsychological Society : JINS|September 20, 2024
Psychometric and adherence considerations for high-frequency, smartphone-based cognitive screening protocols in older adultsLouisa I Thompson, Alyssa N De Vito, Zachary J Kunicki, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 20, 2025
TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's diseaseStephen Salloway, Andrew Pain, Elly Lee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 29, 2023
Remote and in-clinic digital cognitive screening tools outperform the MoCA to distinguish cerebral amyloid status among cognitively healthy older adultsLouisa I Thompson, Zachary J Kunicki, Sheina Emrani, et al.
JAMA Neurology|November 18, 2024
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer DiseaseStephen Salloway, Jakub Wojtowicz, Nicola Voyle, et al.
JAMA Network Open|July 13, 2026
Age, Multidomain Lifestyle Intervention, and White Matter Integrity: Secondary Analysis of the POINTER Randomized Clinical TrialPauline Maillard, Prashanthi Vemuri, Danielle J Harvey, et al.
Annals of Neurology|March 26, 2011
Amyloid-β associated cortical thinning in clinically normal elderlyJ Alex Becker, Trey Hedden, Jeremy Carmasin, et al.
Brain : a Journal of Neurology|January 13, 2017
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognitionMichael J Pontecorvo, Michael D Devous, Michael Navitsky, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentLuka Kulic, Fabien Alcaraz, Gregory Klein, et al.
Journal of the International Neuropsychological Society : JINS|January 29, 2016
Two Novel Psychomotor Tasks in Idiopathic Normal Pressure HydrocephalusMaria A Rossetti, Irene Piryatinsky, Fayeza S Ahmed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 3, 2024
Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumabTianle Chen, John O'Gorman, Carmen Castrillo-Viguera, et al.
Pageof 18